Status:

COMPLETED

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Lead Sponsor:

Daiichi Sankyo

Collaborating Sponsors:

Daiichi Sankyo Deutschland GmbH

Conditions:

Non-valvular Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

This study is designed to gain real-world clinical data on the peri- and post-procedural usage of anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation (NVAF) unde...

Detailed Description

The study will assess real-world evidence data of anticoagulation and antiplatelet therapy in patients with NVAF undergoing PCI treated with edoxaban. The observation period will start 4 to 72 hours a...

Eligibility Criteria

Inclusion

  • ≥ 18 years of age
  • Providing written informed consent (ICF) for participation in the study
  • NVAF treated with edoxaban
  • Successful PCI
  • No planned elective cardiac intervention for the whole duration of the study (up to 1 year)
  • Capability of patients for follow-up by telephone by the site for the whole duration of the study (up to 1 year)
  • Availability of patients for follow-up by telephone by the site for the whole duration of the study (up to 1 year)
  • Willingness of patients for follow-up by telephone by the site for the whole duration of the study (up to 1 year)
  • Not simultaneously participating in any interventional study
  • Life expectancy \> 1 year

Exclusion

  • Not applicable

Key Trial Info

Start Date :

June 30 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 6 2023

Estimated Enrollment :

666 Patients enrolled

Trial Details

Trial ID

NCT04519944

Start Date

June 30 2020

End Date

July 6 2023

Last Update

August 2 2023

Active Locations (66)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (66 locations)

1

Zentralklinik Bad Berka

Bad Berka, Germany, 99437

2

SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald

Bad Friedrichshall, Germany, 74177

3

Kerckhoff-Klinik GmbH

Bad Nauheim, Germany, 61231

4

Herz- und Diabeteszentrum Nordrhein-Westfalen

Bad Oeynhausen, Germany, 32545

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | DecenTrialz